Clem Jones Centre for Ageing Dementia Research, Queensland Brain Institute, The University of Queensland, Brisbane, QLD, Australia.
Clem Jones Centre for Ageing Dementia Research, Queensland Brain Institute, The University of Queensland, Brisbane, QLD, Australia.
Adv Drug Deliv Rev. 2020;165-166:1-14. doi: 10.1016/j.addr.2019.11.009. Epub 2019 Nov 29.
The blood-brain barrier (BBB) is a dynamic structure that functions as a gatekeeper, reflecting the unique requirements of the brain. In this review, following a brief historical overview of how the concepts of the BBB and the neurovascular unit (NVU) developed, we describe its physiology and architecture, which pose a particular challenge to therapeutic intervention. We then discuss how the restrictive nature of this barrier can be overcome for the delivery of therapeutic agents. Alterations to drug formulation offer one option, in part by utilizing distinct transport modes; another is invasive or non-invasive strategies to bypass the BBB. An emerging non-invasive technology for targeted drug delivery is focused ultrasound that allows for the safe and reversible disruption of the BBB. We discuss the underlying mechanisms and provide an outlook, emphasizing the need for more research into the NVU and investment in innovative technologies to overcome the BBB for drug delivery.
血脑屏障(BBB)是一种动态结构,作为守门员,反映了大脑的独特需求。在这篇综述中,在简要回顾了血脑屏障和神经血管单元(NVU)概念的发展之后,我们描述了其生理学和结构,这对治疗干预构成了特殊挑战。然后,我们讨论了如何克服这种屏障的限制,以输送治疗剂。改变药物制剂是一种选择,部分是通过利用不同的运输方式;另一种是通过侵入性或非侵入性策略绕过血脑屏障。一种新兴的针对药物输送的非侵入性技术是聚焦超声,它可以安全且可逆地破坏血脑屏障。我们讨论了潜在的机制,并提供了一个展望,强调需要对 NVU 进行更多的研究,并投资于创新技术,以克服血脑屏障进行药物输送。